Daniel Drucker
@danieljdrucker.bsky.social
A clinician scientist at LTRI @sinaihealth studying Glucagon, GIP, GLP-1, GLP-2, diabetes, obesity, metabolism and the gut endocrine system
A reminder of the primary endpoint in the evoke trials, the change in the CDR – Sum of Boxes (CDR-SB) score from baseline to week 104 #Alzheimers www.understandingalzheimersdisease.com/-/media/File...
November 22, 2025 at 11:58 AM
A reminder of the primary endpoint in the evoke trials, the change in the CDR – Sum of Boxes (CDR-SB) score from baseline to week 104 #Alzheimers www.understandingalzheimersdisease.com/-/media/File...